
Global & Singapore Cancer Therapeutics Market to 2031
Description
The cancer therapeutics market in Singapore is propelled by strong government backing and continuous advancements in research and innovation. With a population exceeding 5 million, Singapore is experiencing a rise in cancer cases, making it one of the top causes of mortality in the country. As global cancer care evolves, Singapore has emerged as a prominent center for oncology drug development, attracting both domestic and international pharmaceutical companies to conduct research and launch new treatments. The market is marked by increasing demand for targeted therapies, immunotherapies, and precision medicine, which have revolutionized cancer treatment by providing more personalized and effective options.
Government-led programs such as the Singapore Cancer Consortium (SCC) and the National Research Foundation (NRF) play crucial roles in promoting oncology research and facilitating clinical trials. The SCC, a partnership among public healthcare institutions, academic bodies, and industry stakeholders, supports cancer biology research, drug discovery, and clinical studies within the country. Through this consortium, Singapore has positioned itself as a leader in precision medicine by conducting clinical trials focused on molecular cancer profiling and the creation of targeted therapies. These initiatives have driven significant progress in personalized treatment approaches, enhancing patient outcomes by tailoring therapies to individual genetic characteristics.
Government-led programs such as the Singapore Cancer Consortium (SCC) and the National Research Foundation (NRF) play crucial roles in promoting oncology research and facilitating clinical trials. The SCC, a partnership among public healthcare institutions, academic bodies, and industry stakeholders, supports cancer biology research, drug discovery, and clinical studies within the country. Through this consortium, Singapore has positioned itself as a leader in precision medicine by conducting clinical trials focused on molecular cancer profiling and the creation of targeted therapies. These initiatives have driven significant progress in personalized treatment approaches, enhancing patient outcomes by tailoring therapies to individual genetic characteristics.
Table of Contents
100 Pages
- 1. Introduction
- 1.1 Report Guidance
- 1.2 Market Segmentation
- 2. Executive Summary
- 2.1 Key Insights
- 3. Research Methodology
- 3.1 Secondary Research
- 3.2 Primary Research
- 3.2.1 Data Triangulation and Validation:
- 4. Singapore Cancer Therapeutics Market Landscape
- 4.1 Overview
- 4.2 Ecosystem Analysis
- 4.2.1 List of Vendors in the Value Chain
- 5. Cancer Therapeutics Market Key Market Dynamics
- 5.1 Cancer Therapeutics Market – Key Market Dynamics
- 5.2 Market Drivers
- 5.3 Market Restraints
- 5.4 Market Opportunities
- 5.5 Future Trends
- 5.6 Impact of Drivers and Restraints
- 6. Singapore Cancer Therapeutics Market – Analysis
- 6.1 Singapore Cancer Therapeutics Market Revenue (US$ Million), 2021–2031
- 6.2 Singapore Cancer Therapeutics Market Revenue and Forecast Analysis
- 7. Singapore Cancer Therapeutics Market Analysis – by Therapy Types
- 7.1 Singapore Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Therapy Types
- 8. Singapore Cancer Therapeutics Market Analysis – by Indications
- 8.1 Singapore Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Indications
- 9. Singapore Cancer Therapeutics Market Analysis – by Distribution Channel
- 9.1 Singapore Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Distribution Channel
- 10. Competitive Landscape
- 10.1 Heat Map Analysis by Key Players
- 10.1 Company Positioning and Concentration
- 11. Industry Landscape
- 11.1 Overview
- 11.2 Market Initiative
- 11.2 Partnerships and Collaborations
- 11.2 Other Developments
- 12. Company Profiles
- 12.1 Bristol-Myers Squibb Co
- 12.1. 1 Key Facts
- 12.1. 2 Business Description
- 12.1. 3 Products and Services
- 12.1. 4 Financial Overview
- 12.1. 5 SWOT Analysis
- 12.1. 6 Key Developments
- 12.2 AbbVie Inc
- 12.2. 1 Key Facts
- 12.2. 2 Business Description
- 12.2. 3 Products and Services
- 12.2. 4 Financial Overview
- 12.2. 5 SWOT Analysis
- 12.2. 6 Key Developments
- 12.3 Johnson & Johnson
- 12.3. 1 Key Facts
- 12.3. 2 Business Description
- 12.3. 3 Products and Services
- 12.3. 4 Financial Overview
- 12.3. 5 SWOT Analysis
- 12.3. 6 Key Developments
- 12.4 F. Hoffmann-La Roche Ltd
- 12.4. 1 Key Facts
- 12.4. 2 Business Description
- 12.4. 3 Products and Services
- 12.4. 4 Financial Overview
- 12.4. 5 SWOT Analysis
- 12.4. 6 Key Developments
- 12.5 Pfizer Inc
- 12.5. 1 Key Facts
- 12.5. 2 Business Description
- 12.5. 3 Products and Services
- 12.5. 4 Financial Overview
- 12.5. 5 SWOT Analysis
- 12.5. 6 Key Developments
- 12.6 AstraZeneca Plc
- 12.6. 1 Key Facts
- 12.6. 2 Business Description
- 12.6. 3 Products and Services
- 12.6. 4 Financial Overview
- 12.6. 5 SWOT Analysis
- 12.6. 6 Key Developments
- 12.7 Merck KGaA
- 12.7. 1 Key Facts
- 12.7. 2 Business Description
- 12.7. 3 Products and Services
- 12.7. 4 Financial Overview
- 12.7. 5 SWOT Analysis
- 12.7. 6 Key Developments
- 12.8 Novartis AG
- 12.8. 1 Key Facts
- 12.8. 2 Business Description
- 12.8. 3 Products and Services
- 12.8. 4 Financial Overview
- 12.8. 5 SWOT Analysis
- 12.8. 6 Key Developments
- 12.9 Astellas Pharma Inc
- 12.9. 1 Key Facts
- 12.9. 2 Business Description
- 12.9. 3 Products and Services
- 12.9. 4 Financial Overview
- 12.9. 5 SWOT Analysis
- 12.9. 6 Key Developments
- 12.10 Eli Lilly and Co
- 12.10. 1 Key Facts
- 12.10. 2 Business Description
- 12.10. 3 Products and Services
- 12.10. 4 Financial Overview
- 12.10. 5 SWOT Analysis
- 12.10. 6 Key Developments
- 13. Appendix
- 13.1 About Business Market Insights
- 13.2 List of Abbreviations
- TABLE OF TABLES
- Table 1. Singapore Cancer Therapeutics Market Segmentation
- Table 2. List of Vendors
- Table 3. Singapore Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million)
- Table 4. Singapore Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million)
- Table 5. Singapore Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Therapy Types
- Table 6. Singapore Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy Types
- Table 7. Singapore Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Indications
- Table 8. Singapore Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications
- Table 9. Singapore Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel
- Table 10. Singapore Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel
- Table 11. List of Abbreviations
- TABLE OF FIGURES
- Figure 1. Impact Analysis of Drivers and Restraints
- Figure 2. Singapore Cancer Therapeutics Market Revenue, (US$ Million), 2021–2031
- Figure 3. Heat Map Analysis by Key Players
- Figure 4. Company Positioning and Concentration
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.